SPARK Neuro SPARK Neuro is a neuroscience company that provides drug development and clinical care solutions. | ![]() Express Diagnostics Int'l Express Diagnostics Int'l is a company that manufactures and distributes DrugCheck, onsite urine and saliva screening devices for the detection of drugs of abuse. | ![]() SurModics SurModics is a provider of surface modification, drug delivery and in vitro diagnostic technologies to the healthcare industry. | ![]() SiteOne Therapeutics SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders. | ![]() Inflazome Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome. | |
Founding Date | Founding Date 2016 | Founding Date 2004 | Founding Date 1979 | Founding Date 2014 | Founding Date 2016 |
Type | Type Private | Type Private | Type Public | Type Private | Type Subsidiary |
Tags | |||||
Locations | Locations Santa Monica, US HQ | Locations Blue Earth, US HQ | Locations Eden Prairie, US HQ Galway, IE Eden Prairie, US | Locations San Francisco, US HQ Bozeman, US | Locations Dublin 2, IE HQ Brisbane City, AU Cambridge, GB |
Employees | Employees 234% decrease | Employees 17 | Employees 3699% increase | Employees 2216% increase | Employees 156% decrease |
Valuation ($) | Valuation ($) 53.5 m | Valuation ($) N/A | Valuation ($) 539.3 m | Valuation ($) 75 m | Valuation ($) N/A |
Funding | |||||
Latest funding round | Latest funding round $ 13.5m (almost 8 years ago) | Latest funding round N/A | Latest funding round N/A | Latest funding round $ 15m (over 9 years ago) | Latest funding round N/A |
Total funding raised | Total funding raised $ 13.5m | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 17.8m | Total funding raised $ 17m |

Express Diagnostics Int'l is a company that manufactures and distributes DrugCheck, onsite urine and saliva screening devices for the detection of drugs of abuse.
View company
SurModics is a provider of surface modification, drug delivery and in vitro diagnostic technologies to the healthcare industry.
View company
SiteOne Therapeutics is a company that develops therapeutics for the treatment of hypersensitivity disorders.
View company
Inflazome engages in developing orally available drugs to address clinical unmet needs in inflammatory diseases by targeting the inflammasome.
View company